Literature DB >> 10702507

Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.

R Pantophlet1, H Seifert, L Brade, H Brade.   

Abstract

The levels of antilipopolysaccharide (anti-LPS) antibodies in patients colonized with an endemic Acinetobacter strain were compared to those in patients with bloodstream infections. Seropositivity and seronegativity correlated with positive and negative blood cultures, respectively, indicating that determination of the level of anti-LPS antibodies is useful for diagnosing Acinetobacter infections.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10702507      PMCID： PMC95863          DOI： 10.1128/CDLI.7.2.293-295.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  9 in total

1.  Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter.

Authors:  E V Vinogradov; R Pantophlet; L Dijkshoorn; L Brade; O Holst; H Brade
Journal:  Eur J Biochem       Date:  1996-08-01

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Use of a murine O-antigen-specific monoclonal antibody to identify Acinetobacter strains of unnamed genomic species 13 Sensu Tjernberg and Ursing.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

7.  Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates.

Authors:  H Seifert; P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 8.  Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Strate; A Schulze; G Pulverer
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

Review 9.  Antibodies to lipopolysaccharide.

Authors:  I R Poxton
Journal:  J Immunol Methods       Date:  1995-10-12       Impact factor: 2.303
  9 in total
  1 in total

1.  Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System.

Authors:  Michal Magda; Serena Bettoni; Maisem Laabei; Derek Fairley; Thomas A Russo; Kristian Riesbeck; Anna M Blom
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.